Clinical Trial Update: Evaluating the Pharmacokinetics, Safety, and Tolerability of Bedaquiline in Infants, Children, and Adolescents With Multidrug-Resistant Tuberculosis, Living With or Without HIV [Phase 1, Phase 2]

View source ↗

Summary

The trial update summarizes pharmacokinetics, safety, and tolerability findings for bedaquiline in infants, children, and adolescents with multidrug-resistant t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Multidrug-resistant Tuberculosis

Drugs mentioned

• bedaquiline (bedaquiline)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Tuberculosis, HIV | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-03-21